Market Cap : 2.66 B | Enterprise Value : 2.22 B | PE Ratio : 26.69 | PB Ratio : 5.08 |
---|
NAS:CORT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:CORT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Corcept Therapeutics's sale of business for the three months ended in Dec. 2020 was $0.0 Mil. It means Corcept Therapeutics gained $0.0 Mil from selling business. Corcept Therapeutics's sale of business for the trailing twelve months (TTM) ended in Dec. 2020 was $0.0 Mil.
Compared with last quarter ($0.0 Mil in Sep. 2020 ), Corcept Therapeutics gained the same money from selling business in Dec. 2020 ($0.0 Mil).
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
The amount earned to sell business.
Sale Of Business for the trailing twelve months (TTM) ended in Dec. 2020 was 0 (Mar. 2020 ) + 0 (Jun. 2020 ) + 0 (Sep. 2020 ) + 0 (Dec. 2020 ) = $0.0 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
No Headline